Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Lexapro (escitalopram) - Important Safety Information from Lundbeck (Ireland) Ltd as approved by the Irish Medicines Board

07 December 2011

Important Safety Information communication from Lundbeck (Ireland) Ltd on the association of Lexapro (escitalopram) with dose-dependent QT interval prolongation.

Important Safety Information - Lexapro

Date Printed: 16 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971